Indoxyl sulfate reduces Ito,f by activating ROS/MAPK and NF-κB signaling pathways
Jing Yang1,2, Hongxia Li1, Chi Zhang1
1Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Abstract:
There is a high prevalence of ventricular arrhythmias related to sudden cardiac death in patients with chronic kidney disease (CKD). To explored the possible mechanism of CKD-related ventricular arrhythmias, a CKD rat model was created, and indoxyl sulfate (IS) was further used in vivo and in vitro. This project used the following methods: patch clamp, electrocardiogram, and some molecular biology experimental techniques. IS was found to be significantly elevated in the serum of CKD rats. Interestingly, the expression levels of the fast transient outward potassium current-related (Ito,f-related) proteins (Kv4.2, Kv4.3, and KChIP2) in the heart of CKD rats and rats treated with IS decreased. IS dose-dependently reduced Ito,f density, accompanied by the decreases in Kv4.2, Kv4.3, and KChIP2 proteins in vitro. IS also prolonged the action potential duration and QT interval, and paroxysmal ventricular tachycardia could be induced by IS. In-depth studies have shown that ROS/p38MAPK, ROS-p44/42 MAPK, and NF-κB signaling pathways play key roles in the reduction of Ito,f density and Ito,f-related proteins caused by IS. These data suggest that IS reduces Ito,f-related proteins and Ito,f density by activating ROS/MAPK and NF-κB signaling pathways, and the action potential duration and QT interval are subsequently prolonged, which contributes to increasing the susceptibility to arrhythmia in CKD.
Insights
Indoxyl sulfate (IS), elevated in chronic kidney disease (CKD), reduces key heart proteins (Kv4.2, Kv4.3, KChIP2) and potassium currents, increasing arrhythmia risk.
Area of Science:
- Cardiology
- Nephrology
- Molecular Biology
Background:
- Patients with chronic kidney disease (CKD) exhibit a high incidence of ventricular arrhythmias and sudden cardiac death.
- The precise mechanisms underlying CKD-related ventricular arrhythmias require further elucidation.
Purpose of the Study:
- To investigate the role of indoxyl sulfate (IS) in the development of ventricular arrhythmias in CKD.
- To explore the molecular mechanisms by which IS affects cardiac ion channels and electrical activity.
Main Methods:
- Establishment of a CKD rat model.
- In vivo and in vitro experiments using indoxyl sulfate (IS).
- Techniques included patch clamp, electrocardiography, and molecular biology assays.
Main Results:
- Indoxyl sulfate (IS) levels were significantly elevated in CKD rats.
- IS reduced the expression of fast transient outward potassium current (Ito,f)-related proteins (Kv4.2, Kv4.3, KChIP2) in cardiac tissue.
- IS dose-dependently decreased Ito,f density, prolonged action potential duration and QT interval, and induced ventricular tachycardia.
- ROS/MAPK and NF-κB signaling pathways were identified as key mediators in IS-induced reduction of Ito,f and related proteins.
Conclusions:
- Indoxyl sulfate (IS) contributes to ventricular arrhythmias in CKD by reducing Ito,f-related proteins and Ito,f density.
- Activation of ROS/MAPK and NF-κB signaling pathways by IS plays a critical role in arrhythmogenesis.
- These findings highlight IS as a potential therapeutic target for preventing cardiac arrhythmias in CKD patients.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of the Unfolded Protein Response
TGF - β Signaling Pathway
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Nitric Oxide Signaling Pathway


